Precision Oncology had a tremendous boost with the 2015 roll-out of the Precision Medicine Initiative. What started with a focus on next generation .. Read more gene sequences for the cancer genome has blossomed into a full set of tools for assaying solid and liquid tumors and the consequent development of analytical assays, analysis software platforms, and precision therapies – biologics, vaccines, and small-molecules. Nowhere has precision oncology been more useful than in developing innovative technologies for tumor heterogeneity. Precision Oncology has benefited from, first, precision sequencing of populations of cells and, second, through development of small drugs and biologics that alone or in combination have boosted the efficacy of therapies. Further, innovations in cell-based therapies (NK cell, CAR-T cell therapies) are in clinical trials; in fact, CAR-T cell therapies have been approved by FDA for selected cancer cases. Come join us for the Precision Oncology Virtual Summit to hear from leaders in academia, biotech, pharma, diagnostics, clinical research, healthcare, and regulatory bodies on this topic!.
- [ Users who have shown interest for this Event ]
- + Add me as user
- Share your Experience